BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 21/08/2026

Government Owned Invention Available for License: Matched Patient-Derived 3D Isocitrate Dehydrogenase (IDH)-Mutant Glioma Cell Lines for Modeling Malignant Transformation

The National Cancer Institute is seeking licensees for matched patient-derived 3D cell lines, 403L and 403H, generated from the same patient before and after a malignant transformation from a WHO grade 2 to a WHO grade 4 disease, to study IDH-mutant glioma progression and treatment resistance.

Source: Federal Register — Health and Human ServicesOpen original release →